Solution Spotlight with Lonza

14:25 - 15:00

Moving multi particulates from pediatric formulation to patient centric drug product design

  • Patient centric drug product design – definition, regulation and outcomes evidence.
  • Review of multiparticulate technology platforms
  • Case study

Prof. Dr. Sven Stegemann, Director Pharmaceutical Business Development, Lonza